| Literature DB >> 25193066 |
Emma Jones1, Nicholas Lees, Graham Martin, Mary Dixon-Woods.
Abstract
BACKGROUND: Quality improvement (QI) methods are widely used in surgery in an effort to improve care, often using techniques such as Plan-Do-Study-Act cycles to implement specific interventions. Explicit definition of both the QI method and quality intervention is necessary to enable the accurate replication of effective interventions in practice, facilitate cumulative learning, reduce research waste and optimise benefits to patients. This systematic review aims to assess quality of reporting of QI methods and quality interventions in perioperative care.Entities:
Mesh:
Year: 2014 PMID: 25193066 PMCID: PMC4159382 DOI: 10.1186/2046-4053-3-98
Source DB: PubMed Journal: Syst Rev ISSN: 2046-4053
Quality improvement taxonomy
| 1. Provider education | Dissemination of information | Educational outreach visits | Component separation training and recurrence rates |
| Distribution of educational material | Cadaveric training and surgeon confidence | ||
| 2. Provider reminder systems | Any ‘clinical encounter-specific’ information intended to prompt a clinician to recall information or consider a specific process of care | Decision aids | MEWS |
| Reminders | The WHO surgical safety checklist | ||
| 3. Patient reminders | Any methods of encouraging patient compliance to self-management | Appointment reminders | SMS exercise reminders before bariatric surgery |
| 4. Promotion of self-management | Access to a resource that enhances the patients' ability to manage their condition | BP devices | Follow up phone calls with recommended adjustments to care |
| Fit Bits/pedometers | |||
| 5. Audit and feedback | Any feedback of clinical performance | PROMs | Percentage of patients achieving target LOS |
| LOS | |||
| Morbidity and mortality | |||
| 6. Patient education | Dissemination of information | Distribution of educational material | Tri-modal pre-habilitation programme compliance and effect on LOS |
| Individual or group sessions | |||
| 7. Organizational change | Any change in organizational structure | Multidisciplinary teams | Changes to staff rota to facilitate early patient mobilization after elective arthroplasty |
| Communication | |||
| Health records | |||
| 8. Financial, regulatory, or legislative incentives | Any financial bonus, reimbursement or provider licensure scheme | Positive or negative incentives for providers or patients | 18-week wait target for elective orthopaedic surgery |
| 9. Facilitated relay of clinical data to providers | Transfer of clinical information from patients to the provider when data was not collected during a patient visit | Telephone call | Relay of BP measurements to the pre-assessment team |
| Postal contact | Collection of postoperative complication data through postal survey |
Adapted from Shojania et al. [24] Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies (Vol. 2: Diabetes Mellitus Care). Technical Reviews, Rockville (MD): Agency for Healthcare Research and Quality (US). LOS length of stay, MEWS Modified Early Warning System, BP blood pressure, WHO World Health Organization, SMS Short Message Service.
Figure 1Search strategy.
Data extraction template items
| Author, year, country, surgical speciality | 1. Brief name | 1. Sample size |
| 2. Why (rationale for intervention) | 2. Baseline measurement | |
| 3. What (materials used to apply the intervention) | 3. Data collection schedule | |
| 4. Procedures (processes used in the intervention) | 4. Data analysis (e.g. driver diagrams) | |
| 5. Who (who delivered the intervention, including level of training) | 5. Data volume/duration (e.g. length of PDSA cycle) | |
| 6. How (mode of delivery: face to face, internet) | 6. Explicit description of prediction of change | |
| 7. Where (location: emergency or elective, and primary or secondary care) | 7. Missing data (and reasons given) | |
| 8. When and how much (duration, dose, intensity) | 8. Description of generalizability | |
| 9. Tailoring (was the intervention planned to be personalised) | 9. Adverse effects (on health care providers and resource utilisation) | |
| 10. Modifications (describe what, why, when and how modifications were made) | 10. Presence and type of patient or stakeholder involvement (collaborative or consultative) | |
| 11. How well (strategies to improve or maintain compliance) | ||
| 12. How well (outcome of compliance assessment) |